Anti-Hu paraneoplastic syndrome presenting with brainstem-cerebellar symptoms and Lambert-Eaton myasthenic syndrome

Neuropathology

Volumn 23, Issue 3, 2003, Pages 230-238

  Nagashima, Toshiko ^a   Mizutani, Yasuyuki ^a   Kawahara, Hiromasa ^a   Maguchi, Shiro ^a   Terayama, Yoshihiko ^a   Shinohara, Toshiya ^a   Orba, Yasuko ^a   Chuma, Takayo ^a   Mano, Yukio ^a   Itoh, Tomoo ^a   Sawa, Hirofumi ^a   Sakai, Koichiro ^b   Motomura, Masakatsu ^c   Nagashima, Kazuo ^a,d  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Kanazawa Medical University   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Anti Hu antibody; Cerebellar ataxia; Lambert Eaton myasthenic syndrome; Paraneoplastic syndrome; Small cell lung cancer

Indexed keywords

ANTIBODY; CISPLATIN; ETOPOSIDE; HU ANTIBODY; MORPHINE; PREDNISOLONE; PYRIDOSTIGMINE; STEROID; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTONOMIC DYSFUNCTION; AUTOPSY; BACKACHE; BRAIN DISEASE; BRAIN STEM; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE REPORT; CEREBELLUM DISEASE; EATON LAMBERT SYNDROME; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; LYMPHOCYTIC INFILTRATION; MALE; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; SPUTUM CYTODIAGNOSIS; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; TUMOR VOLUME;

AUTOANTIBODIES; BLOTTING, WESTERN; BRAIN STEM; CARCINOMA, SMALL CELL; CEREBELLUM; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; LAMBERT-EATON MYASTHENIC SYNDROME; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PARANEOPLASTIC CEREBELLAR DEGENERATION; RNA-BINDING PROTEINS;

EID: 0141534389     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1789.2003.00501.x     Document Type: Article

References (44)

1. Henson RA & Urich H. Cancer and the Nervous System. The Neurological Manifestation of Systemic Malignant Disease. Oxford: Blackwell Scientific, 1982.
2. Posner JB. Paraneoplastic syndromes. In: Posner JB (ed.) Neurologic Complications of Cancer. Contemporary Neurology, Series 45. Philadelphia: FA Davis, 1995; 353-385.
3. Graus F, Cordon-Cardo C, Posner JB. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 1985; 35: 538-543.
4. Moll JW, Antoine JC, Brashear HR et al. Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies. Neurology 1995; 45: 1937-1941.
5. Motomura M, Johnston I, Lang B, Vincent A, Newson-Davis J. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 1995; 58: 85-87.
6. Dalmau J & Rosenfeld MR. Characterization of neuronal antigens and anti-neuronal antibodies. Methods Neurosci 1995; 24: 261-271.
7. Sakai K, Ogasawara T, Hirose G, Jaeckle KA, Greenlee JE. Analysis of autoantibody binding to 52-kd paraneoplastic cerebellar degeneration. Associated antigen expressed in recombinant proteins. Ann Neurol 1993; 33: 373-380.
8. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine 1992; 71: 59-72.
9. Grisold W, Drlicek M, Liszka-Setinek U, Wondrusch E. Anti-tumour therapy in paraneoplastic neurological disease. Clin Neurol Neurosurg 1995; 97: 106-111.
10. Uchuya M, Graus F, Vega F, Rene R, Delattre J-Y. Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J Neurol Neurosurg Psychiatry 1996; 60: 388-392.
11. Takamori M. A nationwide survey on paraneoplastic neurological syndromes. Project group on paraneoplastic neurological syndromes, Neuroimmunological Disease Research Committee, the Ministry of Health and Welfare, Japan (in Japanese). Rinsho Shinkeigaku 1997; 37: 93-98.
12. Graus F, Dalmou J, Rene R et al. Anti-Hu antibodies in patients with small-cell lung cancer: Association with complete response to therapy and improved survival. J Clin Oncol 1997; 15: 2866-2872.
13. Keime-Guibert F, Graus F, Broet P et al. Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor. Neurology 1999; 53: 1719-1723.
14. Rojas I, Graus F, Keime-Guibert F et al. Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology 2000; 55: 713-715.
15. Chalk CH, Murray MF, Newsom-Davis J, O'Neill JH, Spiro SG. Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma. Neurology 1990; 40: 1552-1556.
16. Bird SJ. Clinical and electrophysiological improvement in Lambert-Eaton syndrome with intravenous immunoglobulin therapy. Neurology 1992; 42: 1422-1423.
17. Paone JF & Jeyasingham K. Remission of cerebellar dysfunction after pneumonectomy for bronchogenic carcinoma. N Eng J Med 1980; 302: 156.
18. Roberts HJV (1967) A case of spino-cerebellar degeneration associated with carcinoma of the prostate. Med J Aust 1967; 1: 391-393.
19. Batson OA, Fantle DM, Stewart JA. Paraneoplastic encephalomyelitis. Dramatic response to chemotherapy alone. Cancer 1992; 69: 1291-1293.
20. Darnell RB & DeAngelis LM. Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 1993; 341: 21-22.
21. Byrne T, Mason WP, Posner JB, Dalmau J. Spontaneous neurological improvement in anti-Hu associated encephalomyelitis. J Neurol Neurosurg Psychiatry 1997; 62: 276-278.
22. Oh SJ, Dropcho EJ, Claussen GC. Anti-Hu-associated paraneoplastic sensory neuropathy responding to early aggressive immunotherapy: Report of two cases and review of literature. Muscle Nerve 1997; 20: 1576-1582.
23. Keime-Guilbert F, Graus F, Rene AF, Honnorat J, Delattre J-Y. Treatment of paraneoplastic syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Pshcyiatry 2000; 68: 479-482.
24. Graus F, Keime-Guilbert F, Rene R et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001; 124: 1138-1148.
25. Yagi Y, Inuzuka T, Takada K et al. Changes in anti-HuD antibody titers in the long term course in paraneoplastic sensory neuropathy. Eur Neurol 1997; 37: 122-123.
26. Verschuuren JJ, Perquin M, ten Velde G, De Baets M, Vriesman PB, Twijnstra A. Anti-Hu antibody titre and brain metastases before and after treatment for small cell lung cancer. J Neurol Neurosurg Psychiatry 1999; 67: 353-357.
27. Molinuevo JL, Graus F, Serrano C, Rene R, Guerrero A, Illa I. Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy. Ann Neurol 1998; 44: 976-980.
28. Blumenfeld AM, Recht LD, Chad DA, DeGirolami U, Griffin T, Jaeckle KA. Coexistence of Lambert-Eaton myasthenic syndrome and subacute cerebellar degeneration: Differential effects of treatment. Neurology 1991; 41: 1682-1685.
29. Fueyo J, Gomez-Manzano C, Pascual J, Pou A. Paraneoplastic syndromes. Neurology 1993; 43: 236.
30. Ohkubo K, Ohishi K, Motomura M, Sakai K, Tsujihata M, Nagataki S. Report of a case of small cell lung cancer associated with Lambert-Eaton myasthenic syndrome and subacute cerebellar degeneration - with a review of the Japanese literature (in Japanese with English abstract). No To Shinkei 1994; 46: 285-289.
31. Graus F, Ribalta T, Campo E, Monforte R, Urbano A, Rozman C. Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitis. Neurology 1990; 40: 219-222.
32. Dalmau J, Furneaux HM, Rosenblum MK, Graus F, Posner JB. Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuropathy. Neurology 1991; 41: 1757-1764.
33. Kawahara M, Furuse K, Kodama N et al. Coexistence of paraneoplastic sensory neuronopathy and Lambert-Eaton myasthenic syndrome. Jpn J Clin Oncol 1994; 24: 224-227.
34. Heidenreich F, Schober R, Brinck U, Hartung HP. Multiple paraneoplastic syndromes in a patient with antibodies to neuronal nucleoproteins (anti-Hu). J Neurol 1995; 242: 210-216.
35. Kleopa KA, Teener JW, Scherer SS, Galetta SL, Bird SJ. Chronic multiple paraneoplastic syndromes. Muscle Nerve 2000; 23: 1767-1772.
36. Sugie M, Yanagimoto S, Mori K, Ueno S. A case of combined paraneoplastic neurological syndrome, with Lambert-Eaton myasthenic syndrome manifesting as severe respiratory failure, and anti-Hu syndrome. Clin Neurol 2001; 41: 418-422.
37. Yoshiioka R, Ueda Y, Sakai K, Negami T, Hirose G. Immunohistochemical studies of paraneoplastic sensory neuropathy - An analysis of antineuronal antibody and infiltrated lymphocytes (in Japanese with English abstract). Rinsho Shinkeigaku 1992; 32: 397-404.
38. Jean WC, Dalmau J, Ho A, Posner JB. Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis. Neurology 1994; 44: 140-147.
39. Verschuuren J, Chuang L, Rosenblum MK et al. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration. Acta Neuropathol (Berl) 1996; 91: 519-525.
40. Altermatt HJ, Rodriguez M, Scheithauer BW, Lennon VA. Paraneoplastic anti-Purkinje and type I antineuronal nuclear autoantibodies bind selectively to central, peripheral, and autonomic nervous system cells. Laboratory Invest 1991; 65: 412-420.
41. Greenlee JE, Parks TN, Jaeckle KA. Type Iia ('anti-Hu') antineuronal antibodies produce destruction of rat cerebellar granule neurons in vitro. Neurology 1993; 43: 2049-2954.
42. Yaginuma M, Ishida K, Uchihara T et al. Paraneoplastic cerebellar ataxia with mild cerebello-olivary degeneration and an anti-neuronal antibody: a clinicopathological study. Neuropathol Appl Neurobiol 2000; 26: 568-572.
43. Yamamoto S, Watanabe Y, Maki Y et al. A case of paraneoplastic cerebellar degeneration (PCD) associated with anti-VGCC antibody. Neuropathology 2001; 21: A29.
44. Benyahia B, Liblau R, Merle-Beral H, Tourani JM, Dalmau J, Delattre JY. Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies. Ann Neurol 1999; 45: 162-167.